ABSTRACT Paediatric rheumatology is an exciting field exploding with new knowledge of autoimmune and autoinflammatory conditions and how to treat them. It is, however, a relatively new subspecialisation in Asia. There is thus a great need to educate the public and medical community about paediatric rheumatic diseases so that children with such conditions are given the highest possibility of achieving normal function in their daily lives.
Paediatric rheumatologists work with a paediatrician or family physician to evaluate and treat conditions involving the musculoskeletal system, and autoimmune or autoinflammatory disorders. A referral to a paediatric rheumatologist should be made for evaluation of:
• Arthritis or enthesitis -swelling, tenderness, warmth, erythema and/or limitation of movement of joints or tendon/ ligament insertions (entheses).
• Autoimmune disorders -systemic lupus erythematosus, scleroderma, vasculitis, inflammatory disorders of the muscle such as dermatomyositis or inflammatory disorders of the eyes/other organs.
• Evaluation of prolonged or recurrent fever.
• Unexplained complaints of chronic musculoskeletal pain, weakness, poor appetite or fatigue.
• Unexplained symptoms such as rash, weight loss, anaemia or joint swelling.
In Singapore, a formal paediatric rheumatology service was set up in National University Hospital (NUH) in 2002 and KK Women's and Children's Hospital (KKH) in 2009. (2) Prior to that, children with rheumatologic diseases were seen by rheumatologists, dermatologists and paediatricians at KKH, Tan Tock Seng Hospital, National Skin Centre and Singapore General Hospital. (3) In 1998, the prevalence of childhood-onset rheumatologic diseases was only 178 cases over a three-year period, (3) but by 2012, the number had increased by approximately nine times. (2) This rise in numbers likely reflects an increasing awareness of childhood-onset rheumatic diseases in Singapore, rather than a true increase in disease prevalence.
In Singapore, we are fortunate to have access to many of the newest advances in medical therapy for paediatric rheumatologic conditions. In addition to classic diseasemodifying antirheumatic drugs (DMARDs) such as methotrexate and sulphasalazine, many biologics with targeted therapy are also available for use in conditions such as JIA and paediatric
Paediatric rheumatology: a subspecialty in its infancy that is making leaps and bounds lupus. These biological agents include anti-tumour necrosis factor (TNF), anti-interleukin-1 and -6, anti-CD20, and more recently, anti-B-lymphocyte stimulator. Intra-articular steroid injections for arthritis in children have also been shown to be a safe and effective therapeutic option. This is supported by an audit on intra-articular steroid injections performed in JIA patients in NUH. (4) The audit showed that joint injections were performed only once in 80.8% of patients with good clinical response and that no incidence of septic arthritis or avascular necrosis was recorded. Physiotherapy and occupational therapy complement therapeutic effort to achieve complete disease quiescence, enabling the child to have a normal life and function. 
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